London, UK (PRWEB) July 30, 2013
Market Publishers Ltd and Select Biosciences signed a partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorised to distribute and sell Select Biosciences research reports.
“Since its formation in 1999, Select Biosciences Limited has been delivering focused market reports, custom scientific consultancy, training courses, exhibitions and conferences for the life sciences market space. Specialising in early-stage therapeutic discovery and omics, the company provides open forums aimed at fostering debate and discussion to advance disease research and development. We are happy to have Select Biosciences as our new partner and offer our clients unrivalled access to a wide selection of reports providing technical and commercial analyses of dynamic markets in the cutting-edge biomedical field,” commented Tanya Levdikova, Assistant Manager at Partners Department at Market Publishers Ltd.
In-demand Market Research Reports by Select Biosciences:
Emerging Pharmaceutical Markets 2012. Mainly due to strong performance in the emerging pharmaceutical markets, the global pharmaceutical market is expected to reach USD 1,020 billion by the end of 2012. The research study provides extensive and coherent information about pharmaceutical markets in emerging countries. It also gives a detailed statistical and analytical review on the demographics, macroeconomic indicators, disease profile, key drivers and restraints of the emerging pharmaceutical markets ...
Single Cell Omics 2011. The market for omics technologies that is projected to grow from USD 60 million in sales in 2010 to USD 525 million in 2016. The report provides a detailed understanding of this emerging market, covering the key technologies, applications, unmet needs and trends. The study also includes an Internet survey administered to a large stratified database; analyses of front-end separation technologies, back-end omics technologies and integrated platforms to bridge the gap; profiles of 30 companies; and a quantitative market model segmented by technologies ...
Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report. The cancer vaccines market landscape and the emerging circulating tumor cells (CTCs) space are evolving and expanding, driven by the greater emphasis on personalized medicine especially in the cancer/oncology field. The research presents a comprehensive industry analysis of these two areas, describing various approaches for the generation of cancer vaccines vis-à-vis their advantages and disadvantages and associated technical characteristics ...
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2013. The study focuses upon technical and business trends in the CTC and CSC markets spaces. Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilised for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research activity vis-a-vis CTCs and CSCs are described in the study. The report also contains an extensive analysis of the various clinical trials where CTCs are being enumerated and analyzed ...
More details on the publisher and its research reports can be found at Select Biosciences page.
Read the full story at http://www.prweb.com/releases/2013/7/prweb10977994.htm.
Copyright©2012 Vocus, Inc.
All rights reserved